Press Releases about Abvc Biopharma Inc
Via NewMediaWire
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
ABVC BioPharma Awarded ADHD Treatment Patent in Australia, a Potential $32 Billion Market
June 25, 2024
Via NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
Via TheNewswire.com
![](http://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
![](http://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
![](http://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Via TheNewswire.com
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Via TheNewswire.com
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Via TheNewswire.com
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
February 12, 2024
Via NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Subscribe Now